Cat. No.: DMM-001262
| Status | Age | Sex |
|---|---|---|
|
|
|
| Model Overview | |
|---|---|
| Model Description | Mutant mice on this background will be useful in studies to establish the nature of diabesity modifier genes in the DBA/2 genome as well as the development of diabetic complications, notably diabetic nephropathy and glaucoma. |
| Strain Name | D2.BKS(D)-Leprdb/J |
| Background Strain | C57BLKS/J |
| SPF | Yes |
| Research Application | Diabetes |
| Target Information | |
|---|---|
| Target Name | Lepr |
| Synonyms | CD295, Fa, LEP-R, Leprb, LEPRD, LEPROT, leptin receptor gene-related protein |
| Gene ID | 3953 |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.